ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

July 9, 2020
Open Access

The Fungal Iron Chelator Desferricoprogen Inhibits Atherosclerotic Plaque Formation

International Journal of Molecular Sciences
László PotorJózsef Balla
July 8, 2020

Apolipoprotein E polymorphism and vitamin K status in cystic fibrosis patients not supplemented with vitamin K

European Review for Medical and Pharmacological Sciences
P Krzyżanowska-JankowskaJ Walkowiak
July 8, 2020
Open Access

A Timing Effect of 17-β Estradiol on Atherosclerotic Lesion Development in Female ApoE-/- Mice

International Journal of Molecular Sciences
Obialunanma V EbenebeAlison K Heather
July 2, 2020

Pineal volume reduction in patients with mild cognitive impairment who converted to Alzheimer's disease

Psychiatry and Clinical Neurosciences
Teruyuki MatsuokaAlzheimer's Disease Neuroimaging Initiative
July 8, 2020
Preprint
Open Access

East Asian-specific novel loci associated with late-onset Alzheimer's disease: the GARD cohort Genome-wide study

MedRxiv : the Preprint Server for Health Sciences
S. KangKun Ho Lee
July 10, 2020

Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease

Human Brain Mapping
Sebastian G PopescuAlzheimer's Disease Neuroimaging Initiative
July 6, 2020

Trace elements and APOE polymorphisms in pregnant women and their new-borns

Environment International
Ajda TrdinIngrid Falnoga
July 9, 2020

Characterization of Exome Variants and Their Metabolic Impact in 6,716 American Indians from the Southwest US

American Journal of Human Genetics
Hye In KimCristopher V Van Hout
July 6, 2020

Enhancing PPARγ  by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Qi GaoWangsen Cao
July 8, 2020

Apolipoprotein E polymorphism carriers exhibit objective cognitive deficits: a single center trial

Neurological Research
Yanfang ZengXiaokun Geng

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/apoe-phenotypes/5f08b7b2-e8f9-419f-ac8f-e19485a1800c